Still need help?
Our expert librarians are here to help you find what you’re looking for.
Evaluate Pharma
Evaluate Pharma offers consensus forecasts and wider analytics, curated and calibrated using proprietary methodologies. This includes comprehensive coverage of sales, deals and financials – including pipeline data and content from exclusive broker relationships.
Other offerings include:
• Transparent and interrogatable methodologies, data sets and sources.
• Application of methodologies to enable robust trending that accommodate changes in sample composition.
• Data is verified and different data sets are calibrated to provide cross comparisons against industry methodologies.
• Ability to link consensus forecasts directly to the pipeline to allow quick analysis of forecasts at indication, therapeutic area and MOA (mechanism of action) levels.
• Comprehensive company model coverage, including tools to conduct strategic/financial analysis (e.g., changing company portfolio dynamics), with constant forecast updates.
• Monthly forecast model updates.
License Information
Users: Named Users Only
Vendor: Evaluate Pharma
Start Date: 2024, Expires:
2026
Coverage
Start Date: 2003